Who owns NVS
1,540 institutions reported holding NVS for 2026Q1, together 7.5% of the company, more than the 1,472 a quarter earlier.
1,540
Institutions reporting a position · as of 2026Q1 · up from 1,472 the quarter before
- Shares held by institutions
- 143.2M
Shares held by institutions · 7.5% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $21.9B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 2.4%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 185
- Positions exited
- 119
- Added to
- 458
- Reduced
- 482
- Top 10 holdersof the company
- 3.6%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 1,540 | 143.2M | $21.9B |
| 2025Q4 | 1,472 | 132.6M | $18.3B |
| 2025Q3 | 1,375 | 133.4M | $17.1B |
| 2025Q2 | 1,355 | 133.0M | $16.1B |
| 2025Q1 | 1,329 | 138.6M | $15.3B |
| 2024Q4 | 1,309 | 129.6M | $12.6B |
| 2024Q3 | 1,286 | 131.4M | $15.1B |
| 2024Q2 | 1,286 | 137.0M | $14.6B |
| 2024Q1 | 1,226 | 138.8M | $13.4B |
| 2023Q4 | 1,243 | 139.9M | $14.1B |
| 2023Q3 | 1,196 | 147.5M | $15.0B |
| 2023Q2 | 1,175 | 147.4M | $14.8B |
| 2023Q1 | 1,156 | 170.5M | $15.1B |
| 2022Q4 | 1,159 | 169.8M | $15.4B |
| 2022Q3 | 1,073 | 178.6M | $13.6B |
| 2022Q2 | 1,124 | 198.7M | $16.8B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Fisher Asset Management, LLC | 13.9M | 0.73% | $2.12B |
| MORGAN STANLEY | 8.5M | 0.45% | $1.30B |
| DIMENSIONAL FUND ADVISORS LP | 8.1M | 0.43% | $1.24B |
| PRIMECAP MANAGEMENT CO/CA/ | 7.6M | 0.40% | $1.16B |
| Dodge & Cox | 7.0M | 0.36% | $1.06B |
| GOLDMAN SACHS GROUP INC | 6.5M | 0.34% | $997M |
| LOOMIS SAYLES & CO L P | 5.4M | 0.28% | $829M |
| BANK OF AMERICA CORP /DE/ | 5.0M | 0.26% | $758M |
| FRANKLIN RESOURCES INC | 3.4M | 0.18% | $521M |
| BlackRock Inc. | 2.9M | 0.15% | $451M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - General
Ranks #10 of 16 by Smart Score